Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WAIT: Semaglutide before Atrial Fibrillation Ablation
NCT07275697Phase 4Recruiting
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in Atrial fibrillation (AFib). Started Mar 2026; status: recruiting.
02
Drugs
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07275697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07275697.